Linagliptin-metformin combo boosts glucose control in type 2 diabetes

05/31/2012 | Endocrine Today

A higher-dose combination of linagliptin and metformin fared better than a high-dose metformin-only treatment in lowering blood glucose levels in patients with type 2 diabetes, a study presented at the American Association of Clinical Endocrinologists meeting showed. The combination treatment was also very well-tolerated in patients over 18 months, a researcher said.

View Full Article in:

Endocrine Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL